J. Beuzen

A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers

Andrew W. Wood, K. Wesnes, J. Beuzen, 1999, Journal of psychopharmacology.

The cost of treatment dropout in depression. A cost-benefit analysis of fluoxetine vs. tricyclics.

F. Meurgey, E. Lévy, C. Le Pen, 1994, Journal of affective disorders.

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

C. Beasley, J. Beuzen, M. Dellva, 1997, European Neuropsychopharmacology.

The Prophylactic Efficacy of Fluoxetine in Unipolar Depression

S. Montgomery, J. Danion, J. Beuzen, 1988, British Journal of Psychiatry.

The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine.

R. Belmaker, G. Tollefson, H. Munitz, 2000, Clinical therapeutics.

Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder

S. Frangou, S. Dursun, R. Devellis, 2005, Psychiatry Research.

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study

G. L’italien, R. Kerwin, B. Millet, 2007, European Psychiatry.